JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by approximately 143,900 shares at a price of around 16.89 Hong Kong dollars per share.
On March 30th, HSBC increased its holdings of Baiyunshan (00874) by 143,924 shares, with a price of 16.8915 Hong Kong dollars per share, for a total amount of approximately 2.4311 million Hong Kong dollars.
Hong Kong Stock Exchange latest data shows that on March 30, JP Morgan increased its holdings of Guangzhou Baiyunshan Pharmaceutical Holdings (00874) by 143,924 shares, with a price of 16.8915 Hong Kong dollars per share, for a total amount of approximately 2.4311 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 19.9102 million shares, with a latest shareholding ratio of 9.05%.
Related Articles
China Galaxy Securities: High oil prices fluctuate, focus on alternative routes for oil.
Sinolink: Collaborative computing included in national strategy, multi-industry resonance on the same frequency.
Energy crisis does not hinder the expansion ambition: Microsoft Corporation (MSFT.US) increases investment in Japan by $10 billion, joining forces with SoftBank and Sakura to build AI cloud infrastructure.
China Galaxy Securities: High oil prices fluctuate, focus on alternative routes for oil.
Sinolink: Collaborative computing included in national strategy, multi-industry resonance on the same frequency.
Energy crisis does not hinder the expansion ambition: Microsoft Corporation (MSFT.US) increases investment in Japan by $10 billion, joining forces with SoftBank and Sakura to build AI cloud infrastructure.
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026
